During the discussion session, participants raised questions on the shift to single-dose HPV vaccination, particularly experiences from Cameroon and the potential for countries like Mauritania to transition from two to one dose. Concerns were voiced about vaccine supply constraints and the risk of discouraging countries if revitalization efforts are hindered by shortages. Delegates highlighted the need for clear timelines on new vaccine availability, cost reductions through broader production, and Gavi’s support for vaccinating boys. Comments also stressed the importance of addressing the socio-economic impact of cervical cancer in advocacy efforts. Questions about safety and potential side effects of single-dose schedules were also raised. The moderators confirmed that upcoming presentations would address these topics in greater depth.